Crescentic IgA nephropathy along with simultaneous cellular and antibody ‐mediated rejection in a kidney transplant leading to rapid allograft failure
Crescentic IgA Nephropathy in a renal transplant can lead to rapid loss of graft function despite treatment. Concurrent treatment ‐resistant acute cellular and antibody‐mediated rejection make the prognosis even worse. AbstractCrescentic IgA Nephropathy in a renal transplant can lead to rapid loss of graft function despite treatment. Concurrent treatment ‐resistant acute cellular and antibody‐mediated rejection make the prognosis even worse.
Source: Clinical Case Reports - Category: General Medicine Authors: Imran Gani,
Daniel Kleven,
Laura Mulloy Tags: CASE REPORT Source Type: research
More News: Bone Graft | General Medicine | Kidney Transplant | Kidney Transplantation | Transplant Surgery | Transplants | Urology & Nephrology